Omega Healthcare Investors, Inc. (OHI) Income Statement

The steady climb in revenue suggests accretive acquisitions and rent escalators are contributing to growth, consistent with the company's disciplined capital deployment. However, the revenue series alone does not isolate organic growth from acquired properties, so investors should monitor same-store performance before extrapolating this trajectory. The sharp swing in NOI margins across quarters warrants further investigation into the timing of non-accrual adjustments and straight-line rent recognition.

The bimodal pattern, with margins near 98% in most quarters and near 47% in others, suggests that periodic revenue reversals or reserve charges may be flowing through the NOI line in specific periods. This pattern may indicate that non-accrual treatment or straight-line rent adjustments are materially affecting reported property-level profitability. Investors should monitor whether the low-margin quarters reflect recurring tenant collectability issues or one-time items before assessing the durability of NOI.

The spike in 2026Q2 FFO, which accompanied a substantial EPS beat, may reflect gains on asset sales or other non-recurring items rather than a durable step-up in recurring cash earnings. The subsequent sharp decline suggests that underlying run-rate FFO is closer to the $0.70 to $0.85 range seen in 2025, which may bear on dividend coverage. Investors should monitor AFFO relative to dividends over multiple quarters rather than relying on any single period.